TRANSCRANIAL BONE MARROW INJECTION
Clinical trials for TRANSCRANIAL BONE MARROW INJECTION explained in plain language.
Never miss a new study
Get alerted when new TRANSCRANIAL BONE MARROW INJECTION trials appear
Sign up with your email to follow new studies for TRANSCRANIAL BONE MARROW INJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bone marrow injection into skull shows promise for major stroke
Disease control Not yet recruitingThis study tests a new drug called RK-4 for people who have had a severe stroke and cannot receive standard clot-removal treatment. The drug is injected directly into the bone marrow of the skull for three days. Researchers want to see if it helps patients recover better and is s…
Matched conditions: TRANSCRANIAL BONE MARROW INJECTION
Phase: PHASE2 • Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New injection into skull marrow aims to help severe stroke patients
Disease control Not yet recruitingThis early-phase study tests an experimental drug called RK-4 in 18 people who have had a severe stroke (large hemispheric infarction) and cannot receive or did not respond to standard clot-removal therapy. The drug is injected directly into the bone marrow of the skull once dail…
Matched conditions: TRANSCRANIAL BONE MARROW INJECTION
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC